Retrospective Study
Copyright ©The Author(s) 2023.
World J Radiol. Jan 28, 2023; 15(1): 20-31
Published online Jan 28, 2023. doi: 10.4329/wjr.v15.i1.20
Table 1 Locations, numbers, and frequencies of salivary gland tumors
Location
n (%)
Unilateral parotid gland61 (83.6)
Submandibular gland6 (8.2)
Minor salivary gland3 (4.1)
Bilateral parotid gland2 (2.7)
Sublingual gland 1 (1.4)
Table 2 Numbers of benign and malignant salivary gland tumors
Benign SGTs
n (%)
Malignant SGTs
n (%)
Warthin’s tumor18 (24.7)Squamous cell carcinoma11 (15.1)
Pleomorphic adenoma14 (19.2)Adenoid cystic carcinoma3 (4.1)
Inflammatory process12 (16.4)Malignant lymphoma3 (4.1)
Lipoma4 (5.5)Adenocarcinoma1 (1.4)
Benign cystic lesions1 (1.4)Mucoepidermoid carcinoma1 (1.4)
Carcinoma ex pleomorphic adenoma 1 (1.4)
Other benign lesions1 (1.4)Acinic cell carcinoma1 (1.4)
Follicular dendritic cell sarcoma1 (1.4)
Salivary duct carcinoma1 (1.4)
Total50 (68.5)23 (31.5)
Table 3 Mean ADC values and quantitative dynamic contrast-enhanced magnetic resonance imaging parameters of different histopathologic salivary gland tumors

Pleomorphic adenoma
Warthin’s tumor
Other benign tumors
Malignant tumors
P value
ADC (× 10−3 mm2/s)1.61 ± 0.26 (a)0.72 ± 0.09 (b)0.77 ± 0.19 (b)0.96 ± 0.33 (b)< 0.001
Ktrans (min−1)0.42 ± 0.350.75 ± 0.550.57 ± 0.370.77 ± 0.560.131
Kep (min−1)0.69 ± 0.33 (a)6.2 ± 3.13 (b)1.95 ± 0.94 (c)1.72 ± 0.92 (c)< 0.001
Ve0.65 ± 0.25 (a)0.11 ± 0.04 (b)0.3 ± 0.12 (c)0.48 ± 0.24 (ac)< 0.001
Table 4 Semiquantitative dynamic contrast-enhanced magnetic resonance imaging parameters of different histopathologic salivary gland tumors
TIC Pattern, n(%)
Tpeak (s)WR (%)
A
B
C
D
Pleomorphic adenomas14 (70.0)0 (0)0 (0)0 (0)202.74 ± 21.48 (a)-
Warthin’s tumors0 (0)18 (66.7)0 (0)0 (0)20.26 ± 11.72 (b)59.33 ± 10.99 (a)
Other benign tumors4 (20.0)4 (14.8)10 (45.5)0 (0)74.94 ± 75.47 (c)17.89 ± 14.99 (b)
Malignant tumors2 (10.0)5 (18.5)12 (54.5)4 (100)60.60 ± 55.78 (c)18.48 ± 18.38 (b)
P value < 0.001< 0.001< 0.001
Table 5 Comparison of pleomorphic adenomas, Warthin’s tumors, and malignant salivary gland tumors by ROC analysis using ADC, Tpeak, Ktrans, Kep, and Ve values
Variable
Cut-off
AUC (95% CI)
Sensitivity
Specificity
PPV
NPV
P value
Pleomorphic adenomas
ADC value> 1.10.977 (0.911-0.998)1.0000.8980.7001.000< 0.001
Tpeak > 120 0.947 (0.868-0.986)1.0000.8980.7001.000< 0.001
Ktrans≤ 0.460.702 (0.584-0.804)0.8570.6270.3530.9490.005
Kep≤ 1.140.926 (0.840-0.974)0.9290.8310.5650.980< 0.001
Ve≥ 0.40.849 (0.746-0.922)0.9290.7290.4480.977< 0.001
Warthin’s tumors
ADC value≤ 0.80.742 (0.626-0.837)0.9440.5820.4250.970< 0.001
Tpeak ≤ 19.1 0.869 (0.769-0.936)0.6670.9090.7060.893< 0.001
WR > 430.981 (0.917-0.999)0.9440.9090.7730.980< 0.001
Ktrans> 0.30.577 (0.455-0.692)0.8890.3460.3080.9050.291
Kep> 2.440.973 (0.905-0.997)1.0000.8550.6921.000< 0.001
Ve≤ 0.170.958 (0.883-0.991)1.0000.9090.7831.000< 0.001
Malignant tumors
ADC value> 0.70.541 (0.420-0.658)0.7830.4400.3910.8150.569
Tpeak ≤ 120 0.531 (0.410-0.649)0.9130.3600.3960.9000.648
WR ≤ 490.562 (0.441-0.678)1.0000.3000.3971.0000.351
Ktrans> 0.530.599 (0.477-0.712)0.6520.6000.4290.7890.194
Kep≤ 3.70.592 (0.471-0.706)1.0000.3000.3971.0000.160
Ve> 0.350.702 (0.584-0.804)0.6960.6600.4850.8250.001